1. Home
  2. XGN vs WEA Comparison

XGN vs WEA Comparison

Compare XGN & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XGN
  • WEA
  • Stock Information
  • Founded
  • XGN 2002
  • WEA 2002
  • Country
  • XGN United States
  • WEA United States
  • Employees
  • XGN N/A
  • WEA N/A
  • Industry
  • XGN Medical Specialities
  • WEA Trusts Except Educational Religious and Charitable
  • Sector
  • XGN Health Care
  • WEA Finance
  • Exchange
  • XGN Nasdaq
  • WEA Nasdaq
  • Market Cap
  • XGN 138.3M
  • WEA 129.0M
  • IPO Year
  • XGN 2019
  • WEA N/A
  • Fundamental
  • Price
  • XGN $7.00
  • WEA $10.79
  • Analyst Decision
  • XGN Strong Buy
  • WEA
  • Analyst Count
  • XGN 2
  • WEA 0
  • Target Price
  • XGN $7.50
  • WEA N/A
  • AVG Volume (30 Days)
  • XGN 237.8K
  • WEA 46.1K
  • Earning Date
  • XGN 08-04-2025
  • WEA 01-01-0001
  • Dividend Yield
  • XGN N/A
  • WEA 7.87%
  • EPS Growth
  • XGN N/A
  • WEA N/A
  • EPS
  • XGN N/A
  • WEA N/A
  • Revenue
  • XGN $56,724,000.00
  • WEA N/A
  • Revenue This Year
  • XGN $19.39
  • WEA N/A
  • Revenue Next Year
  • XGN $13.27
  • WEA N/A
  • P/E Ratio
  • XGN N/A
  • WEA N/A
  • Revenue Growth
  • XGN 1.78
  • WEA N/A
  • 52 Week Low
  • XGN $1.71
  • WEA $9.60
  • 52 Week High
  • XGN $7.95
  • WEA $11.29
  • Technical
  • Relative Strength Index (RSI)
  • XGN 52.23
  • WEA 55.27
  • Support Level
  • XGN $6.62
  • WEA $10.69
  • Resistance Level
  • XGN $7.35
  • WEA $10.84
  • Average True Range (ATR)
  • XGN 0.48
  • WEA 0.09
  • MACD
  • XGN -0.10
  • WEA 0.00
  • Stochastic Oscillator
  • XGN 29.63
  • WEA 50.00

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

About WEA Western Asset Bond Fund Share of Beneficial Interest

Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.

Share on Social Networks: